FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2180207848> ?p ?o ?g. }

• W2180207848 endingPage "1316" @default.
• W2180207848 startingPage "1302" @default.
• W2180207848 abstract "An increasing number of studies demonstrate that administration of either conditioned media (CM) or extracellular vesicles (EVs) released by mesenchymal stromal cells (MSCs) derived from bone marrow and other sources are as effective as the MSCs themselves in mitigating inflammation and injury. The goal of the current study was to determine whether xenogeneic administration of CM or EVs from human bone marrow-derived MSCs would be effective in a model of mixed Th2/Th17, neutrophilic-mediated allergic airway inflammation, reflective of severe refractory asthma, induced by repeated mucosal exposure to Aspergillus hyphal extract (AHE) in immunocompetent C57Bl/6 mice. Systemic administration of both CM and EVs isolated from human and murine MSCs, but not human lung fibroblasts, at the onset of antigen challenge in previously sensitized mice significantly ameliorated the AHE-provoked increases in airway hyperreactivity (AHR), lung inflammation, and the antigen-specific CD4 T-cell Th2 and Th17 phenotype. Notably, both CM and EVs from human MSCs (hMSCs) were generally more potent than those from mouse MSCs (mMSCs) in most of the outcome measures. The weak cross-linking agent 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride was found to inhibit release of both soluble mediators and EVs, fully negating effects of systemically administered hMSCs but only partly inhibited the ameliorating effects of mMSCs. These results demonstrate potent xenogeneic effects of CM and EVs from hMSCs in an immunocompetent mouse model of allergic airway inflammation and they also show differences in mechanisms of action of hMSCs versus mMSCs to mitigate AHR and lung inflammation in this model.There is a growing experience demonstrating benefit of mesenchymal stromal cell (MSC)-based cell therapies in preclinical models of asthma. In the current study, conditioned media (CM) and, in particular, the extracellular vesicle fraction obtained from the CM were as potent as the MSCs themselves in mitigating Th2/Th17-mediated allergic airway inflammation in a mouse model of severe refractory clinical asthma. Moreover, human MSC CM and extracellular vesicles were effective in this immunocompetent mouse model. These data add to a growing scientific basis for initiating clinical trials of MSCs or extracellular vesicles derived from MSCs in severe refractory asthma and provide further insight into the mechanisms by which the MSCs may ameliorate the asthma." @default.
• W2180207848 created "2016-06-24" @default.
• W2180207848 creator A5001097129 @default.
• W2180207848 creator A5002384167 @default.
• W2180207848 creator A5009209916 @default.
• W2180207848 creator A5023770202 @default.
• W2180207848 creator A5025893006 @default.
• W2180207848 creator A5029337515 @default.
• W2180207848 creator A5031473990 @default.
• W2180207848 creator A5051609710 @default.
• W2180207848 creator A5052675103 @default.
• W2180207848 creator A5061426484 @default.
• W2180207848 creator A5067117503 @default.
• W2180207848 creator A5069340456 @default.
• W2180207848 creator A5072989337 @default.
• W2180207848 creator A5085125003 @default.
• W2180207848 creator A5091455922 @default.
• W2180207848 date "2015-09-16" @default.
• W2180207848 modified "2023-10-10" @default.
• W2180207848 title "Systemic Administration of Human Bone Marrow-Derived Mesenchymal Stromal Cell Extracellular Vesicles Ameliorates <i>Aspergillus</i> Hyphal Extract-Induced Allergic Airway Inflammation in Immunocompetent Mice" @default.
• W2180207848 cites W1479842253 @default.
• W2180207848 cites W1540637363 @default.
• W2180207848 cites W1726957010 @default.
• W2180207848 cites W1877686344 @default.
• W2180207848 cites W1968734200 @default.
• W2180207848 cites W1981804859 @default.
• W2180207848 cites W1987348882 @default.
• W2180207848 cites W1987394175 @default.
• W2180207848 cites W1988830115 @default.
• W2180207848 cites W1989796399 @default.
• W2180207848 cites W1993658046 @default.
• W2180207848 cites W1998650056 @default.
• W2180207848 cites W2003172313 @default.
• W2180207848 cites W2013782157 @default.
• W2180207848 cites W2015164426 @default.
• W2180207848 cites W2017985218 @default.
• W2180207848 cites W2020233428 @default.
• W2180207848 cites W2024895549 @default.
• W2180207848 cites W2031433161 @default.
• W2180207848 cites W2031889217 @default.
• W2180207848 cites W2039975971 @default.
• W2180207848 cites W2042487476 @default.
• W2180207848 cites W2043031595 @default.
• W2180207848 cites W2043263890 @default.
• W2180207848 cites W2044638539 @default.
• W2180207848 cites W2071424821 @default.
• W2180207848 cites W2075266563 @default.
• W2180207848 cites W2078142671 @default.
• W2180207848 cites W2082604867 @default.
• W2180207848 cites W2082896113 @default.
• W2180207848 cites W2084526560 @default.
• W2180207848 cites W2085832445 @default.
• W2180207848 cites W2090625436 @default.
• W2180207848 cites W2097310235 @default.
• W2180207848 cites W2099491642 @default.
• W2180207848 cites W2110681571 @default.
• W2180207848 cites W2116670910 @default.
• W2180207848 cites W2118525061 @default.
• W2180207848 cites W2119774673 @default.
• W2180207848 cites W2121354606 @default.
• W2180207848 cites W2122174032 @default.
• W2180207848 cites W2126465607 @default.
• W2180207848 cites W2132317259 @default.
• W2180207848 cites W2145815234 @default.
• W2180207848 cites W2151503854 @default.
• W2180207848 cites W2154215235 @default.
• W2180207848 cites W2156561769 @default.
• W2180207848 cites W2157499746 @default.
• W2180207848 cites W2159401023 @default.
• W2180207848 cites W2160330354 @default.
• W2180207848 cites W2165537330 @default.
• W2180207848 cites W2166672922 @default.
• W2180207848 cites W4229575383 @default.
• W2180207848 doi "https://doi.org/10.5966/sctm.2014-0280" @default.
• W2180207848 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4622402" @default.
• W2180207848 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26378259" @default.
• W2180207848 hasPublicationYear "2015" @default.
• W2180207848 type Work @default.
• W2180207848 sameAs 2180207848 @default.
• W2180207848 citedByCount "177" @default.
• W2180207848 countsByYear W21802078482015 @default.
• W2180207848 countsByYear W21802078482016 @default.
• W2180207848 countsByYear W21802078482017 @default.
• W2180207848 countsByYear W21802078482018 @default.
• W2180207848 countsByYear W21802078482019 @default.
• W2180207848 countsByYear W21802078482020 @default.
• W2180207848 countsByYear W21802078482021 @default.
• W2180207848 countsByYear W21802078482022 @default.
• W2180207848 countsByYear W21802078482023 @default.
• W2180207848 crossrefType "journal-article" @default.
• W2180207848 hasAuthorship W2180207848A5001097129 @default.
• W2180207848 hasAuthorship W2180207848A5002384167 @default.
• W2180207848 hasAuthorship W2180207848A5009209916 @default.
• W2180207848 hasAuthorship W2180207848A5023770202 @default.
• W2180207848 hasAuthorship W2180207848A5025893006 @default.
• W2180207848 hasAuthorship W2180207848A5029337515 @default.
• W2180207848 hasAuthorship W2180207848A5031473990 @default.
• W2180207848 hasAuthorship W2180207848A5051609710 @default.

• next